TEACHER
- Organizing Committee Members
- International Committee
- Company Presentations
- Entrepreneur Pitch
- Session 1&2 – Global Biotech Development
- Session 3 – International Collaboration Strategy
- Session 4 – Exit Strategies for Early Stage New Drug Companies
- Session 5 – New Modalities to Cure
- Session 6 - BIO Asia–Taiwan 2022 Opening & Award Ceremony
- Session 7 - Future Pandemic Preparedness
- Session 8 – Healthcare Innovation Strategy
- Session 9 – Winning the Global Competition with Taiwanese DNA
- Session 10 – AI & Digital Health
- Session 11 – Novel Platforms for Biopharma Discovery
- Session 12 – Biologics Product Development and Manufacturing
- Session 13 – Advances in Cell & Gene Therapy
- Session 14 – CDMO Business for Small Molecules
- Special Forum – Emerging Opportunities when ICT meets BIO
- Session 16- AFOB Net Zero Emission Bioeconomy
- Session 17-Life Science Ventures in Australia
- Session 18-Life Science Ventures in India
- Session 19-Life Science Ventures in Japan
- Session 20-Life Science Ventures in Singapore
- Session 21-Life Science Ventures in UK
- Session 22–Life Science Ventures in Lithuania
- Satellite Conference
Jung Hsin Lin
Session 11 – Novel Platforms for Biopharma Discovery
Date：29 July (Friday)
Time: 09:00 – 10:30 (GMT+8)
Jung –Hsin Lin
Deputy Director
Biomedical Translation Research Center, Academia Sinica
The research focuses of Dr. Jung-Hsin Lin are on the development of novel methods for computational drug discovery and structural bioinformatics, and their innovative applications for exploring new therapeutic candidates and biomolecular targets of natural product molecules and other pharmaceutical agents.
Speech title & Synopsis
.
.
